instruction:
In this task, you need to Translate Czech text to English.
question:
Vynález se týká elektrody, která umoznuje pri umístení na vhodném míste povrchu kuze elektricky stimulovat pod ním procházející vhodné nervové pletence. Výhodne lze pomocí elektrody podle vynálezu lécit chorobnou funkci dolních cest mocových tak, aby nedocházelo k samovolným únikum moce (mocové inkontinenci). Elektroda obsahuje pulkulový kontaktní prvek (1) pro prilození na pokozku nad stimulované nervy, jádro (4), které je vodive spojeno s kontaktním prvkem (1), a permanentní magnet (3) ve tvaru válce, který je souose nasazen na jádro (4) a je orientován svým severním pólem k pulkulovému kontaktnímu prvku (1). Stabilizacní kotouc (6) a prostredek (5) pro upevnení na koncetinu jsou navleceny na jádro (4) mezi permanentní magnet (3) a podlozku (8) a zajisteny maticí (7).
answer:
BACKGROUND OF THE INVENTION The present invention relates to an electrode which, when positioned at a suitable location on the surface of the skin, electrically stimulates the underlying neural girdle beneath it. Advantageously, the electrode of the invention can treat the disease function of the lower urinary tract so as to prevent spontaneous urinary incontinence. The electrode comprises a pulse contact element (1) for adhering to the stimulated nerves, a core (4) which is conductively connected to the contact element (1), and a permanent magnet (3) in the form of a cylinder which is coaxially mounted on the core (4). ) and is oriented with its north pole to the pulse contact element (1). The stabilizing disc (6) and means (5) for attachment to the limb are threaded onto the core (4) between the permanent magnet (3) and the washer (8) and secured by a nut (7).


question:
Podstata zařízení spočívá v tom, že  v pícce je uložen blok černého tělesa,  který má na čelní stěně zapuštěnou destičku  z materiálu, jehož emisivlta má být  ověřena. Před čelní stěnou bloku černého  tělesa je vytvořena tepelná clona proudí­  cího vzduchu. Řešení lze využít pro provozní  kontrolu bezkontaktních a kontaktních  měřidel.
answer:
The essence of the device is that  a black body block is stored in the furnace  which has a recessed plate on the front wall  from the material whose emissivity is to be  verified. In front of a black block front  the body is created by a heat shield flowing  air. The solution can be used for operational  contactless and contactless control  gauges.


question:
e en  se t²k  slou enin obecn ho vzorce I, kde R.sup.1.n. p°edstavuje atom vod ku, hydroxylovou skupinu, skupinu -O(C.sub.1.n.-C.sub.4.n. alkyl), -OCOC.sub.6.n.H.sub.5.n., -OCO(C.sub.1.n.-C.sub.6.n. alkyl) nebo -OSO.sub.2.n.(C.sub.4.n.-C.sub.6.n. alkyl); R.sup.2.n. p°edstavuje C.sub.1.n.-C.sub.6.n. alkylovou skupinu, C.sub.5.n.-C.sub.7.n. cykloalkyl, kter² je pop° pad  substituovan² 1 a  3 substituenty vybran²mi ze souboru zahrnuj c ho C.sub.1.n.-C.sub.4.n. alkylovou skupinu, C.sub.1.n.-C.sub.4.n. alkoxylovou skupinu, hydroxyskupinu, aminoskupinu, nitroskupinu, a atom halogenu; X p°edstavuje skupinu -CH(OH)- nebo -CH.sub.2.n.-; M p°edstavuje skupinu -CH.sub.2.n.CH.sub.2.n.- nebo -CH=CH-; n p°edstavuje   slo 2 nebo 3; a R.sup.3.n. p°edstavuje skupiny 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrroli-dinyl, 4-morfolino, dimethylamino, diethylamino nebo 1-hexamethylenimino; nebo jej  farmaceuticky p°ijateln  s l nebo solv t.  e en  se tak  t²k  zp sobu pou it  slou enin podle p°edkl dan ho vyn lezu pro l  en  r zn²ch l ka°sk²ch indikac , souvisej c ch s postmenopaus ln m syndromem, d lo n m fibroidn m onemocn n m, endometri zou a proliferac  bun k aort ln ho hladk ho svalstva.  e en  se tak  t²k  farmaceutick²ch kompozic, obsahuj c ch slou eniny obecn ho vzorce I a meziprodukt  p°i p° prav  slou enin obecn ho vzorce I.\
answer:

In the present invention there are disclosed compounds of the general formula I, in which Re1 represents a hydrogen atom, a hydroxyl group, the group -O(Ci1-Ci4 alkyl), -OCOCi6Hi5, -OCO(Ci1-Ci6 alkyl) or -OSOi2(Ci4-Ci6 alkyl); Re2 represents alkyl group containing 1 to 6 carbon atoms, a cycloalkyl group having 5 to 7 carbon atoms, and can be optionally substituted with 1 to 3 substituents being selected from the group comprising alkyl group containing 1 to 4 carbon atoms, alkoxyl group having 1 to 4 carbon atoms, a hydroxy group, an amino group, a nitro group, and a halogen atom; X represents the group -CH(OH)- or -CHi2-; M represents the group -CHi2CHi2- or -CH=CH-; n is the number 2 or 3; and Re3 represents the 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrroli-dinyl, 4-morpholino, dimethylamino, diethylamino or 1-hexamethylenimino group or pharmaceutically acceptable salt or solvate thereof. The invention also relates to a method of using the compounds according to the present invention for treating various medicinal indications connected with postmenopausal syndrome, uterine fibroid disease, endometriosis and cell proliferation of  aortal smooth musculature. In the present invention there are also claimed disclosed pharmaceutical compositions containing compounds of the general formula I and intermediates for preparing the compounds of the general formula I.